1Â Executive Summary |
2.ASEAN & Korea Interventional Oncology Market Introduction |
2.1. ASEAN & Korea Interventional Oncology Market – Taxonomy |
2.2. ASEAN & Korea Interventional Oncology Market –Definitions |
2.2.1. By Product |
2.2.2. By Cancer Type |
2.2.3. By Procedure |
2.2.4. By Distribution Channel |
2.2.5. By Country |
3. ASEAN & Korea Interventional Oncology Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. ASEAN & Korea Interventional Oncology Market Dynamic Factors - Impact Analysis |
3.6. Impact of COVID-19 on The Market |
3.7. Three Forecast Scenarios - Pessimistic, Conservative, and Opportunistic |
3.8. Mapping Market Players’ Activities |
3.9. Recent Key Developments |
3.10. Financial Status of the Market Players |
3.11. Recent Acquisitions, Collaborations, and Mergers |
4. ASEAN & Korea Interventional Oncology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. ASEAN & Korea Interventional Oncology Market Forecast, By Product, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1. Radioembolic Agents |
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Non-Radio embolic Agents |
5.2.1. Microspheres |
5.2.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Coated Beads |
5.2.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.2.3. Microparticles |
5.2.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3.3. Market Opportunity Analysis |
5.3. Ablation Devices |
5.3.1. Radiofrequency (RF) Ablation Devices |
5.3.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.1.3. Market Opportunity Analysis |
5.3.2. Microwave Ablation Devices |
5.3.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.2.3. Market Opportunity Analysis |
5.3.3. Cryoablation Devices |
5.3.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.3.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3.3. Market Opportunity Analysis |
5.3.4. Other Ablation Devices |
5.3.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.3.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.4.3. Market Opportunity Analysis |
5.4. Support Devices |
5.4.1. Microcatheters |
5.4.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.1.3. Market Opportunity Analysis |
5.4.2. Guidewires |
5.4.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.2.3. Market Opportunity Analysis |
6. ASEAN & Korea Interventional Oncology Market Forecast, By Cancer Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1. Lung cancer |
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Breast cancer |
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Prostate cancer |
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Cervical cancer |
6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Colorectal cancer |
6.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Acute Myeloid Leukemia |
6.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Others |
6.7.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
7. ASEAN & Korea Interventional Oncology Market Forecast, By Procedure, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1. Thermal Tumor Ablation |
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Non-Thermal Tumor Ablation |
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Transcatheter Arterial Chemoembolization |
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Transcatheter Arterial Embolization/Bland Embolization |
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. ASEAN & Korea Interventional Oncology Market Forecast, By Distribution Channel, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.1. Hospital Pharmacy |
8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Ambulatory Surgery Centers |
8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Research & Academic Institutes |
8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9. ASEAN & Korea Interventional Oncology Market Forecast, By Country, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.1. Indonesia |
9.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Malaysia |
9.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Singapore |
9.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. The Philippines |
9.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Vietnam |
9.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Thailand |
9.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.6.3. Market Opportunity Analysis |
9.7. Korea |
9.7.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.7.3. Market Opportunity Analysis |
9.8. ASEAN & Korea Interventional Oncology Market - Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, By Distribution Channel, and Country, 2022 - 2028 |
10.Indonesia Interventional Oncology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
10.1. By Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Radioembolic Agents |
10.1.2. Non-Radio embolic Agents |
10.1.2.1. Microspheres |
10.1.2.2. Coated Beads |
10.1.2.3. Microparticles |
10.1.3. Ablation Devices |
10.1.3.1. Radiofrequency (RF) Ablation Devices |
10.1.3.2. Microwave Ablation Devices |
10.1.3.3. Cryoablation Devices |
10.1.3.4. Other Ablation Devices |
10.1.4. Support Devices |
10.1.4.1. Microcatheters |
10.1.4.2. Guidewires |
10.2. By Cancer Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Lung cancer |
10.2.2. Breast cancer |
10.2.3. Prostate cancer |
10.2.4. Cervical cancer |
10.2.5. Colorectal cancer |
10.2.6. Acute Myeloid Leukemia |
10.2.7. Others |
10.3. By Procedure Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Thermal Tumor Ablation |
10.3.2. Non-Thermal Tumor Ablation |
10.3.3. Transcatheter Arterial Chemoembolization |
10.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
10.3.5. Transcatheter Arterial Embolization/Bland Embolization |
10.4. By Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.4.1. Hospital Pharmacy |
10.4.2. Ambulatory Surgery Centers |
10.4.3. Research & Academic Institutes |
10.5. Indonesia Interventional Oncology Market - Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 - 2028 |
10.6. Indonesia Interventional Oncology Market Dynamics – Trends |
11 Malaysia Interventional Oncology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
11.1. By Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Radioembolic Agents |
11.1.2. Non-Radio embolic Agents |
11.1.2.1. Microspheres |
11.1.2.2. Coated Beads |
11.1.2.3. Microparticles |
11.1.3. Ablation Devices |
11.1.3.1. Radiofrequency (RF) Ablation Devices |
11.1.3.2. Microwave Ablation Devices |
11.1.3.3. Cryoablation Devices |
11.1.3.4. Other Ablation Devices |
11.1.4. Support Devices |
11.1.4.1. Microcatheters |
11.1.4.2. Guidewires |
11.2. By Cancer Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Lung cancer |
11.2.2. Breast cancer |
11.2.3. Prostate cancer |
11.2.4. Cervical cancer |
11.2.5. Colorectal cancer |
11.2.6. Acute Myeloid Leukemia |
11.2.7. Others |
11.3. By Procedure Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Thermal Tumor Ablation |
11.3.2. Non-Thermal Tumor Ablation |
11.3.3. Transcatheter Arterial Chemoembolization |
11.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
11.3.5. Transcatheter Arterial Embolization/Bland Embolization |
11.4. By Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Hospital Pharmacy |
11.4.2. Ambulatory Surgery Centers |
11.4.3. Research & Academic Institutes |
11.5. Malaysia Interventional Oncology Market - Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 - 2028 |
11.6. Malaysia Interventional Oncology Market Dynamics – Trends |
12. Singapore Interventional Oncology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
12.1. By Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Radioembolic Agents |
12.1.2. Non-Radio embolic Agents |
12.1.2.1. Microspheres |
12.1.2.2. Coated Beads |
12.1.2.3. Microparticles |
12.1.3. Ablation Devices |
12.1.3.1. Radiofrequency (RF) Ablation Devices |
12.1.3.2. Microwave Ablation Devices |
12.1.3.3. Cryoablation Devices |
12.1.3.4. Other Ablation Devices |
12.1.4. Support Devices |
12.1.4.1. Microcatheters |
12.1.4.2. Guidewires |
12.2. By Cancer Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Lung cancer |
12.2.2. Breast cancer |
12.2.3. Prostate cancer |
12.2.4. Cervical cancer |
12.2.5. Colorectal cancer |
12.2.6. Acute Myeloid Leukemia |
12.2.7. Others |
12.3. By Procedure Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Thermal Tumor Ablation |
12.3.2. Non-Thermal Tumor Ablation |
12.3.3. Transcatheter Arterial Chemoembolization |
12.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
12.3.5. Transcatheter Arterial Embolization/Bland Embolization |
12.4. By Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
12.4.1. Hospital Pharmacy |
12.4.2. Ambulatory Surgery Centers |
12.4.3. Research & Academic Institutes |
12.5. Singapore Interventional Oncology Market - Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 - 2028 |
12.6. Singapore Interventional Oncology Market Dynamics – Trends |
13.The Philippines Interventional Oncology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
13.1. By Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Radioembolic Agents |
13.1.2. Non-Radio embolic Agents |
13.1.2.1. Microspheres |
13.1.2.2. Coated Beads |
13.1.2.3. Microparticles |
13.1.3. Ablation Devices |
13.1.3.1. Radiofrequency (RF) Ablation Devices |
13.1.3.2. Microwave Ablation Devices |
13.1.3.3. Cryoablation Devices |
13.1.3.4. Other Ablation Devices |
13.1.4. Support Devices |
13.1.4.1. Microcatheters |
13.1.4.2. Guidewires |
13.2. By Cancer Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Lung cancer |
13.2.2. Breast cancer |
13.2.3. Prostate cancer |
13.2.4. Cervical cancer |
13.2.5. Colorectal cancer |
13.2.6. Acute Myeloid Leukemia |
13.2.7. Others |
13.3. By Procedure Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Thermal Tumor Ablation |
13.3.2. Non-Thermal Tumor Ablation |
13.3.3. Transcatheter Arterial Chemoembolization |
13.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
13.3.5. Transcatheter Arterial Embolization/Bland Embolization |
13.4. By Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
13.4.1. Hospital Pharmacy |
13.4.2. Ambulatory Surgery Centers |
13.4.3. Research & Academic Institutes |
13.5. The Philippines Interventional Oncology Market - Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 - 2028 |
13.6. The Philippines Interventional Oncology Market Dynamics – Trends |
14. Vietnam Interventional Oncology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
14.1. By Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Radioembolic Agents |
14.1.2. Non-Radio embolic Agents |
14.1.2.1. Microspheres |
14.1.2.2. Coated Beads |
14.1.2.3. Microparticles |
14.1.3. Ablation Devices |
14.1.3.1. Radiofrequency (RF) Ablation Devices |
14.1.3.2. Microwave Ablation Devices |
14.1.3.3. Cryoablation Devices |
14.1.3.4. Other Ablation Devices |
14.1.4. Support Devices |
14.1.4.1. Microcatheters |
14.1.4.2. Guidewires |
14.2. By Cancer Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Lung cancer |
14.2.2. Breast cancer |
14.2.3. Prostate cancer |
14.2.4. Cervical cancer |
14.2.5. Colorectal cancer |
14.2.6. Acute Myeloid Leukemia |
14.2.7. Others |
14.3. By Procedure Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
14.3.1. Thermal Tumor Ablation |
14.3.2. Non-Thermal Tumor Ablation |
14.3.3. Transcatheter Arterial Chemoembolization |
14.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
14.3.5. Transcatheter Arterial Embolization/Bland Embolization |
14.4. By Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
14.4.1. Hospital Pharmacy |
14.4.2. Ambulatory Surgery Centers |
14.4.3. Research & Academic Institutes |
14.5. Vietnam Interventional Oncology Market - Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 - 2028 |
14.6. Vietnam Interventional Oncology Market Dynamics – Trends |
15. Thailand Interventional Oncology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
15.1. By Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
15.1.1. Radioembolic Agents |
15.1.2. Non-Radio embolic Agents |
15.1.2.1. Microspheres |
15.1.2.2. Coated Beads |
15.1.2.3. Microparticles |
15.1.3. Ablation Devices |
15.1.3.1. Radiofrequency (RF) Ablation Devices |
15.1.3.2. Microwave Ablation Devices |
15.1.3.3. Cryoablation Devices |
15.1.3.4. Other Ablation Devices |
15.1.4. Support Devices |
15.1.4.1. Microcatheters |
15.1.4.2. Guidewires |
15.2. By Cancer Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
15.2.1. Lung cancer |
15.2.2. Breast cancer |
15.2.3. Prostate cancer |
15.2.4. Cervical cancer |
15.2.5. Colorectal cancer |
15.2.6. Acute Myeloid Leukemia |
15.2.7. Others |
15.3. By Procedure Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
15.3.1. Thermal Tumor Ablation |
15.3.2. Non-Thermal Tumor Ablation |
15.3.3. Transcatheter Arterial Chemoembolization |
15.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
15.3.5. Transcatheter Arterial Embolization/Bland Embolization |
15.4. By Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
15.4.1. Hospital Pharmacy |
15.4.2. Ambulatory Surgery Centers |
15.4.3. Research & Academic Institutes |
15.5. Thailand Interventional Oncology Market - Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 - 2028 |
15.6. Thailand Interventional Oncology Market Dynamics – Trends |
16. Korea Interventional Oncology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
16.1. By Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
16.1.1. Radioembolic Agents |
16.1.2. Non-Radio embolic Agents |
16.1.2.1. Microspheres |
16.1.2.2. Coated Beads |
16.1.2.3. Microparticles |
16.1.3. Ablation Devices |
16.1.3.1. Radiofrequency (RF) Ablation Devices |
16.1.3.2. Microwave Ablation Devices |
16.1.3.3. Cryoablation Devices |
16.1.3.4. Other Ablation Devices |
16.1.4. Support Devices |
16.1.4.1. Microcatheters |
16.1.4.2. Guidewires |
16.2. By Cancer Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
16.2.1. Lung cancer |
16.2.2. Breast cancer |
16.2.3. Prostate cancer |
16.2.4. Cervical cancer |
16.2.5. Colorectal cancer |
16.2.6. Acute Myeloid Leukemia |
16.2.7. Others |
16.3. By Procedure Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
16.3.1. Thermal Tumor Ablation |
16.3.2. Non-Thermal Tumor Ablation |
16.3.3. Transcatheter Arterial Chemoembolization |
16.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
16.3.5. Transcatheter Arterial Embolization/Bland Embolization |
16.4. By Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
16.4.1. Hospital Pharmacy |
16.4.2. Ambulatory Surgery Centers |
16.4.3. Research & Academic Institutes |
16.5. Korea Interventional Oncology Market - Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 - 2028 |
16.6. Korea Interventional Oncology Market Dynamics – Trends |
17. Competition Landscape |
17.1. Strategic Dashboard of Top Market Players |
17.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
17.2.1. Medtronic |
17.2.2. Boston Scientific |
17.2.3. Terumo |
17.2.4. Merit Medical |
17.2.5. AngioDynamics |
17.2.6. J&J |
17.2.7. Teleflex |
17.2.8. Cook Medical |
17.2.9. HealthTronics |
17.2.10. MedWaves |
17.2.11. Sanarus |
17.2.12. IMBiotechnologies |
17.2.13. Trod Medical |
17.2.14. IceCure Medical |
17.2.15. Mermaid Medicals |
17.2.16. Interface Biomaterials BV |
17.2.17. Guerbet |
17.2.18. ABK Biomedical |
17.2.19. Shape Memory Medical |
17.2.20. Endo Shape |
17.2.21. Monteris Medical |
17.2.22. Instylla |
17.2.23. Trisalus Lifesciences |
17.2.24. Profound Medical Corp |
17.2.25. SirtexAccuray |
17.2.26. Baylis Medical |
17.2.27. ALPINION MEDICAL SYSTEMS |
18. Research Methodology |
19. Key Assumptions and Acronyms |
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.